Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.47 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.42 |
| ▸ | PRKCG | P05129 | 1/20 | 0.42 |
| ▸ | PRKCB | P05771 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | PRKCH | P24723 | 1/20 | 0.42 |
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.42 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.42 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13286571 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL8640439 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL2979663 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL13286596 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL8644713 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL1933450 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL2978664 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL8641694 | 1.00 | TDP1 (0.50) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL22499935 | 0.98 | TDP1 (0.48) | TDP1USP2LPAR1LPAR3LPAR2 | |
| SCHEMBL25289202 | 0.98 | TDP1 (0.52) | TDP1USP2LPAR1LPAR3LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104619690-B | Method for producing glycolide having rectification step by gas-liquid countercurrent contact, and method for refining crude glycolide | 株式会社吴羽 | 2016-10-12 | — | — | CN | disclosed |
| US-20160236112-A1 | METHOD FOR PRODUCING GLYCOLIDE, WHICH IS PROVIDED WITH RECTIFICATION STEP BY MEANS OF GAS-LIQUID COUNTERCURRENT CONTACT, AND METHOD FOR PURIFYING CRUDE GLYCOLIDE | KUREHA CORPORATION (JP) | 2016-08-18 | — | — | US | disclosed |
| US-9365536-B2 | Method for producing glycolide, which is provided with rectification step by means of gas-liquid countercurrent contact, and method for purifying crude glycolide | KUREHA CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| EP-2924030-A1 | METHOD FOR PRODUCING GLYCOLIDE, WHICH IS PROVIDED WITH RECTIFICATION STEP BY MEANS OF GAS-LIQUID COUNTERCURRENT CONTACT, AND METHOD FOR PURIFYING CRUDE GLYCOLIDE | Kureha Corporation (JP) | 2015-09-30 | — | — | EP | disclosed |
| US-20150259320-A1 | METHOD FOR PRODUCING GLYCOLIDE, WHICH IS PROVIDED WITH RECTIFICATION STEP BY MEANS OF GAS-LIQUID COUNTERCURRENT CONTACT, AND METHOD FOR PURIFYING CRUDE GLYCOLIDE | KUREHA CORPORATION (JP) | 2015-09-17 | — | — | US | disclosed |
| CN-104619690-A | Method for producing glycolide having rectification step by gas-liquid countercurrent contact, and method for refining crude glycolide | KUREHA CORP | 2015-05-13 | — | — | CN | disclosed |
| US-7776808-B2 | Being lead-free or high melting, with a mixture of benzyl alcohol, a glycol, and an amino alcohol such as diethanolamine; electronics | KAKEN TECH CO., LTD. (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20080305979-A1 | Cleaning agent for removing solder flux and method for cleaning solder flux | KAKEN TECH CO., LTD | 2008-12-11 | — | — | US | disclosed |
| US-7435711-B2 | Cleaning agent for removing solder flux and method for cleaning solder flux | KAKEN TECH CO., LTD. (JP) | 2008-10-14 | — | — | US | disclosed |
| US-20060223732-A1 | Cleaning agent for removing solder flux and method for cleaning solder flux | KAKEN TECH CO., LTD. (JP) | 2006-10-05 | — | — | US | disclosed |
| US-5723250-A | Process for image formation using liquid developer | FUJI XEROX CO., LTD. (JP) | 1998-03-03 | — | — | US | disclosed |
| US-5622804-A | COMPOSITION INCLUDING CARRIER COMPRISING ETHER COMPOUND, CHARGE DIRECTOR, DISPERSED TONER PARTICLES COMPRISING INSOLUBLE THERMOPLASTIC RESIN, COLORANT, CHARGE CONTROL AGENT | FUJI XEROX CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| US-5352557-A | Ether compound as carrier liquid | FUJI XEROX CO., LTD. (JP) | 1994-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259320-A1 | METHOD FOR PRODUCING GLYCOLIDE, WHICH IS PROVIDED WITH RECTIFICATION STEP BY MEANS OF GAS-LIQUID COUNTERCURRENT CONTACT, AND METHOD FOR PURIFYING CRUDE GLYCOLIDE | GK, DDOST, AGL | TDP1 2140/4885USP2 913/4885LPAR1 909/4885 |
| US-20160236112-A1 | METHOD FOR PRODUCING GLYCOLIDE, WHICH IS PROVIDED WITH RECTIFICATION STEP BY MEANS OF GAS-LIQUID COUNTERCURRENT CONTACT, AND METHOD FOR PURIFYING CRUDE GLYCOLIDE | GK, AGL, DDOST | TDP1 1981/4885USP2 967/4885LPAR1 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.